ReNeuron Group Plc (RENE), a British stem cell technology firm, said on Monday that it has appointed its Chief Financial Officer, Catherine Isted as Chief Executive Officer, with effect from September 1.
Following the departure of the former CEO Olav Hellebø in February, Isted has worked closely with the executive management team, led by Iain Ross.
Isted, who joined the ReNeuron as CFO in 2021, has around 25 years' of experience across the healthcare industry.
Isted had joined ReNeuron from Oxford Biomedica Plc, a cell and gene therapy firm, where she was instrumental in raising in excess of 110 million pounds.
For comments and feedback contact: editorial@rttnews.com
Business News
April 24, 2026 15:15 ET Economics news flow was relatively light this week even as the conflict in the Middle East continued, raising concerns for policymakers. In the U.S., spending data, initial jobless claims and pending home sales were the highlights. Business confidence in the biggest euro area economy was in focus in Europe. Inflation data from Japan gained attention in Asia.